...
首页> 外文期刊>International immunopharmacology >HSPA12B attenuates acute lung injury during endotoxemia in mice
【24h】

HSPA12B attenuates acute lung injury during endotoxemia in mice

机译:HSPA12B减轻小鼠内毒素血症期间的急性肺损伤

获取原文
获取原文并翻译 | 示例

摘要

Acute lung injury (ALI) is a critical manifestation of sepsis/septic shock. Heat shock protein A12B (HSPA12B), an endothelial cell-expressed heat shock protein, shows a negative regulation of lipopolysaccharide (LPS)-induced inflammation in myocardium and endothelial cells. However, it is unclear whether HSPA12B exerts protective effects against ALI during sepsis/septic shock. In this study, we treated HSPA12B transgenic mice (Tg) and wild type littermates (WT) with LPS for 6 h to induce endotoxemia. LPS treatment significantly caused pulmonary injuries as evidenced by microarchitecture destruction, vascular leakage and neutrophil recruitment in lungs of WT mice. However, the LPS-induced pulmonary injuries were significantly attenuated in Tg mice. Moreover, the LPS-induced activation of extracellular signal-regulated kinases (ERKs) and upregulation of intercellular adhesion molecule-1 (ICAM-1) and Cyclooxygenase-2 (Cox-2) were inhibited in Tg lungs compared with that in WT mice. Additionally, Tg lungs showed a significant lower level of vascular endothelial growth factor (VEGF) compared with WT mice. Our results demonstrate a pulmonary protective effect of HSPA12B against endotoxin challenge, which indicates management of HSPA12B expression could serve as a potential therapeutic target for ALI during sepsis/septic shock. (C) 2015 Elsevier B.V. All rights reserved.
机译:急性肺损伤(ALI)是败血症/败血性休克的重要表现。热休克蛋白A12B(HSPA12B)是一种表达内皮细胞的热休克蛋白,它对脂多糖(LPS)引起的心肌和内皮细胞炎症反应具有负调节作用。但是,尚不清楚HSPA12B是否在败血症/败血性休克期间对ALI发挥保护作用。在这项研究中,我们用LPS处理HSPA12B转基因小鼠(Tg)和野生型同窝动物(WT)6小时,以诱导内毒素血症。 LPS处理可显着引起肺损伤,如WT小鼠肺部的微结构破坏,血管渗漏和中性粒细胞募集所证明。但是,LPS诱导的肺损伤在Tg小鼠中明显减轻。此外,与WT小鼠相比,在Tg肺中,LPS诱导的细胞外信号调节激酶(ERKs)的激活以及细胞间粘附分子-1(ICAM-1)和环氧合酶-2(Cox-2)的上调受到抑制。此外,与WT小鼠相比,Tg肺显示出显着较低的血管内皮生长因子(VEGF)水平。我们的结果证明了HSPA12B对内毒素攻击的肺保护作用,这表明HSPA12B表达的管理可以作为败血症/败血性休克期间ALI的潜在治疗靶标。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号